Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo
View the full release here: https://www.businesswire.com/news/home/20230131005411/en/
- View the full release here: https://www.businesswire.com/news/home/20230131005411/en/
Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisory Board Member) and Ben Lamm (Colossal Co-Founder and CEO). - Since launching in September 2021, Colossal has raised $225M in total funding.
- Colossal is on a mission to reverse these staggering statistics through genetic rescue techniques and its de-extinction toolkit.
- Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth.